baber/WOPTO huggingface dataset:
Patent JP-2001527677-A (JP)
Title: 補助作動つきのプリンタ
IPC: B41J29/00
Filed: 1998-05-11
Abstract: (57)【要約】
アイデイカード用のプロセッサ（１０）はカードをホッパ（１４）から受取り、カードを印刷のためグラフィックイメージ装置（３０）に通す。印刷前、または印刷後に、カード（５７）は割出しテーブル（４４）上に配置され、割出しテーブルはカードを軸線の周りに運動せしめて別の位置とし、別の作業を行う。空間を節約するために、別の作業はグラフィックイメージ装置（３０）内のカード（５７）の運動の平面とは離れた場所（５２）で行われる。割出しテーブル（４４）は３６０度の範囲内の任意所望の回転位置に割出し可能であり、積極的駆動装置（３２，６４，６８，１０２）によってカード（５７）を割出しテーブル（４４）へ、及びテーブルから運動せしめる。
Patent NZ-170401-A (NZ)
Title: Dispensing package with oral contraceptives in unit dosage form in predetermined sequence
Inventor: SEGRE E
IPC: A61K38/22
Filed: 1973-04-12
Abstract: This invention relates to a method of fertility control by use of novel cyclic progestogen-interrupted estrogen oral contraceptive regimens. Considering the first day of menstrual flow as day one of a 28 day medication administration cycle, a combined formulation of estrogen and progestogen substances is administered on the 3rd, 4th, 5th or 6th day of the cycle and every second or third day thereafter through, and including, the 23rd, 24th, 25th, 26th, 27th or 28th day of the cycle, and a formulation having only a progestogen substance as the active component is administered on the 4th, 5th, 6th, or 7th day of the cycle and every day thereafter on which a combination formulation is not administered, through, and including, the 22nd, 23rd, 24th, 25th, 26th, 27th or 28th day of the cycle.
Patent NZ-204213-A (NZ)
Title: Ar-substituted 2,3,3a,4,5,9a-hexahydro-1h-benz(f)isoindoles and pharmaceutical compositions
Inventor: DE BERNARDIS J F
IPC: C07D209/62
Filed: 1983-05-12
Abstract: Disclosed herein are tetrahydro-benzo [e] isoindolines useful in the treatment of hypertension, which are represented by the formula <CHEM> wherein R, R1, and R2 are independently selected from hydrogen, hydroxy, loweralkoxy of 1 to 3 carbon atoms, loweralkenyloxy of 1 to 3 carbon atoms, benzyloxy, benzoyloxy, thiomethyl, halo, or <CHEM> wherein R4 and R5 are independently selected from hydrogen, loweracyl of 1 to 4 carbon atoms or sulfonyl of the formula <CHEM> wherein R6 is loweralkyl of 1 to 4 carbon atoms; or R and R1, or R1 and R2 can be taken together to form a methylenedioxy or ethylenedioxy bridge; with the proviso that at least one of R, R1 or R2 must be other than hydrogen; and R3 is hydrogen; loweralkyl of 1 to 4 carbon atoms; halo-substituted loweralkyl of 1 to 4 carbon atoms; arylalkyl of the formula <CHEM> wherein m is 0, 1 or 2, p is 0 or 1, R7 is hydrogen or loweralkyl of 1 to 4 carbon atoms and R8 and R9 are independently selected from hydrogen, hydroxy, methoxy, loweralkyl of 1 to 4 carbon atoms, or halo, or R8 and R9 can be taken together to form a methylendioxy or ethylenedioxy bridge; or 1,4-benzodioxan.
Patent NZ-217341-A (NZ)
Title: Analgesic/anti-inflammatory compositions in the form of multiphase tablets
Inventor: ELGER G A
IPC: A61K9/24
Filed: 1986-08-25
Abstract: A pharmaceutical composition in the form of a multiphase (especially a bilayered, optionally coated) tablet. The tablet has a narcotic analgesic phase containing a therapeutically effective quantity of a narcotic analgesic or an analgesically effective salt thereof (e.g. codeine phosphate) and a non-steroidal anti-inflammatory phase containing a therapeutically effective quantity of a non-steroidal anti-inflammatory carboxylic acid or an anti-inflammatory salt or ester thereof (e.g. ibuprofen). The narcotic analgesic phase is free from a non-steroidal anti-inflammatory carboxylic acid or salt or ester thereof, stearic acid and a.stearate salt, and the non-steroidal anti-inflammatory phase is free from a narcotic analgesic or salt thereof, stearic acid and a stearate salt. Further, both the narcotic analgesic phase and the non-steroidal anti-inflammatory phase contain a self-lubricating, compression aid, especially a self-lubricating, direct compression aid, such as microcrystalline cellulose.
Patent NZ-221125-A (NZ)
Title: Panel display system
Inventor: WILSON MERVYN
IPC: E04B2/74
Filed: 1987-07-20
Abstract: A display assembly (Fig. l) comprises a plurality of panels (l) joined together by elongate connecting members (2, 3). Each panel has a removable frame formed by extrusions (6) in each of which is a slot (l3) having a restricted entrance (Fig. 2). Each connecting member (2, 3) has two heads (l8) which can be slid into slots (l3) in adjacent panels (l), from one end, to join the panels together, each head being too wide to pass through the restricted entrance of the slot. A central body portion (20) of the connecting member, to which the heads (l8) are joined, is positioned between, and extends outwards between, adjacent panels to facilitate access to the connecting member and enable the screen assembly to be dismantled easily. A longitudinal slot (50), (Figs. 2l to 23), can be provided in a part of the body (20) that is accessible between connected panels, to enable components such as shelf-supporting brackets to be secured to the screen assembly. To increase the versatility of the assembly, a variety of connecting members (Figs. 4 to l2) can be provided, enabling panels to be joined together in a common plane or in planes inclined to one another and in one or more tiers, and the assembly can also include panels connected together by poles (34) and clips (35) (Fig. l6). The connecting members (2, 3) can be extended components and may be of hollow cylindrical construction (Figs. l0 and ll).
Patent NZ-223161-A (NZ)
Title: Polyester film coated with polyvinylidene chloride (pvdc)
Inventor: GROSJEAN PIERRE
IPC: C08J7/048
Filed: 1988-01-12
Abstract: Composite, typically coextruded polyvinylidene chloride (PVDC)-coated polyester films, well adapted, e.g., as packaging materials, include a sulfonated copolyester interlayer which serves as a primer for improvedly adhering the PVDC topcoat to the polyester base.
Patent NZ-240147-A (NZ)
Title: Ferrocenoyl acyl hydrazines, their preparation and use in insecticidal compositions
Inventor: MICHELOTTI ENRIQUE LOUIS
IPC: A01N55/02
Filed: 1991-10-08
Abstract: Insecticicidal compounds of the formula <CHEM> wherein one of A or B is ferrocenyl and the other of A or B is phenyl or substituted phenyl and R is branched alkyl are effective in controlling the Southern Armyworm and Mexican Bean Beetle.
Patent NZ-242669-A (NZ)
Title: Nanocrystalline magnetic particles having a core of fe3 o4 and/or gamma-fe2 o3 and a chemisorbed coating consisting of natural or synthetic glycosaminoglycans; diagnostic and therapeutic agents
Inventor: KRESSE MAYK
IPC: A61K49/00
Filed: 1992-05-08
Abstract: The invention relates to nanocrystalline magnetic particles consisting of a magnetic iron oxide core composed of Fe3O4,  gamma -Fe2O3 or mixtures thereof and of a shell chemisorbed onto this core, to processes for the production of these particles and to the use thereof in medical diagnosis and therapy. The magnetic particles according to the invention are distinguished by the shell material being composed of natural or synthetic glycosaminoglycans and their derivatives with molecular weights of 500 Da to 250,000 Da and being optionally covalently crosslinked by suitable crosslinkers and/or modified by specific additives.
Patent NZ-257419-A (NZ)
Title: Dental implant fixture; structural details
Inventor: HANSSON STIG GUSTAV VILHELM
IPC: A61C8/00
Filed: 1993-10-25
Abstract: PCT No. PCT/SE93/00871 Sec. 371 Date Apr. 26, 1995 Sec. 102(e) Date Apr. 26, 1995 PCT Filed Oct. 25, 1993 PCT Pub. No. WO94/09717 PCT Pub. Date May 11, 1994A fixture, for use in a dental implant system, of the type having an upper portion with a conically flaring outer surface. The conically flaring outer surface is provided with a circumferentially oriented, defined micro-roughness, preferably in the form of threads or beads, having a height between 0.02 and 0.20 mm, and most preferably approximately 0.1 mm. In the preferred embodiment, the distance between adjacent threads or beads, crest to crest, is approximately twice the height of the threads or beads, respectively.
Patent NZ-260842-A (NZ)
Title: 4-phenylsulphonylamino-5-phenyl(oxy, -thio or -methyl)-6-oxy(-thio or -amino)alkyl-substituted carbamic acid esters, amides and -carbonate esters thereof
Inventor: BREU VOLKER
IPC: C07D239/69
Filed: 1994-06-24
Abstract: Compounds of the formula <IMAGE> in which R<1> to R<9>, R<a>, R<b>, X, Y, Z, m and n have the meaning given in the description, can be used as medicines, in particular for the treatment and prophylaxis of conditions associated with endothelin activities.
Patent NZ-264229-A (NZ)
Title: 11beta-benzaldoxime-estra-4,9-diene derivatives and pharmceutical compositions
Inventor: SCHUBERT GERD
IPC: C07J41/00
Filed: 1994-08-12
Abstract: 11-Benzaldoxime-oestradiene derivatives of the general formula I <IMAGE> and their pharmaceutically acceptable salts, a process for their preparation and pharmaceutical compositions containing them are described. The described compounds display potent antigestagenic effects with lower glucocorticoid activity.
Patent NZ-265995-A (NZ)
Title: Wrap around carton packing machine with carton open end tuck panel folding feet
Inventor: MUELLER ROLF
IPC: B65B11/10
Filed: 1994-05-13
Abstract: PCT No. PCT/GB94/01032 Sec. 371 Date Dec. 8, 1995 Sec. 102(e) Date Dec. 8, 1995 PCT Filed May 13, 1994 PCT Pub. No. WO94/26593 PCT Pub. Date Nov. 24, 1994A carton packaging apparatus for use in wrapping open-ended sleeve type carton blanks around a pre-formed group of articles being moved along a path of travel through a packaging machine as disclosed. The apparatus includes a series of spaced guide members (30) which move along the path of travel and are adapted to engage one of the side panels (12, 13) of a successive series of carton blanks (10) being moved along the path of travel. The guide members are spaced so as to engage the leading edge and trailing edge of each one of the paperboard blanks as they are advanced along the path of the travel. Each guide member has an engagement element (35) which has an elongated link (36) with a foot (37) formed at one end, the other end of the link being pivotally fastened to the guide member. Each of the engagement elements moves with its respective guide member as a pin (38) projecting from the link is received within a groove (39) formed as a part of the apparatus for movement of the link, and thus the foot, relative to the movement of the guide member along the path of the travel for urging a trailing tuck panel of the carton blank into a position adjacent the side panel of the carton blank as the carton blank is being wrapped about the pre-formed group of articles. The apparatus is also provided with at least one guide wall (41) positioned with respect to the path of travel for guiding the side panels of the carton blank downward and about the group of articles, and a rotating wheel (42) also adapted to fold the sides of the carton blank about the pre-formed group of articles.
Patent NZ-283534-A (NZ)
Title: Layered crystalline and amorphous hydrated sodium and potassium silicates, preparation and use in cleaning compositions
Inventor: BORGSTEDT ERIC VON REHREN
IPC: C01B33/38
Filed: 1995-03-15
Abstract: A crystalline hydrated layered sodium and potassium silicate/amorphous sodium and potassium silicate composite material with predetermined hardness ion sequestration properties is achieved by controlling the process for forming the material. The process for producing the crystalline hydrated layered sodium and potassium silicate/amorphous is sodium and potassium silicate composite comprises hydrolyzing DB-1 crystalline sodium and potassium silicate glasses as a precursor material to produce the composite material known as DB-2. Hydrolysis of the DB-1 precursor material is achieved by adding typically up to 100.0 milliequivalents per gram of H3O+ ions or up to 50 milliequivalents per gram of OH- ions. The resulting DB-2 material can sequester CA2+ ions, Mg+ ions, or both, depending on the results desired, processing conditions, and starting materials used.
Patent NZ-300261-A (NZ)
Title: Luminaire with lamellae having concave outer edges for providing more uniform illumination
Inventor: HOLTEN PETRUS ADRIANUS JOSEPHU
IPC: F21V11/02
Filed: 1996-02-08
Abstract: A luminaire has a housing with a light emission window (2), a tubular lamp supported in the housing facing the window (2) and having a center line extending in a plane P perpendicular to the window (2), side reflectors (5), and three-dimensional lamellae (10) which each have an outer edge (11) and a pair of inner edges (12). The outer edge of each lamellae is concave in a direction transverse to the window. The luminaire thus provides an optimized cut-off angle, screening light which would otherwise be dazzling but permitting non-dazzling light to pass. Each of the lamellae has a concave curvature in a direction parallel to the plane P but which flattens out going from plane P towards the side-reflectors (5). That enlarges the aperture through which light emanates and makes the illumination provided by the luminaire more uniform.
Patent NZ-324453-A (NZ)
Title: 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol for topical administration in order to inhibit rejection reactions at organ or bone marrow transplantation or treating autoimmune disease
Inventor: FUJII TSUNEO
IPC: A61K9/02
Filed: 1996-12-24
Abstract: An external preparation in the form of an ointment, paste, liniment, lotion, plaster, cataplasm, eyedrop, suppository, fomentation, inhalant, spray, aerosol, paint, nasal drop, cream, tape and a patch comprising 2-amino-(2-(octylphenyl)ethyl)propane-1,3-diol.
Patent NZ-332936-A (NZ)
Title: Folder for papers comprising a tongue insertable into a pocket and limited by a stop in the pocket
Inventor: HEYER HANS
IPC: B42F7/02
Filed: 1997-05-16
Abstract: A folder for papers (S), comprising a cover (1) and a base (2) operatively joined together by a back (3), wherein the back (3) is adjustable in width (y) to accommodate a height of a stack of papers, wherein the back (3) extends on a base side into a tongue (4} said tongue being insertable and movable in a pocket (5), said tongue constituting an insertable tongue said pocket_being joined to the base (2), and movement of the insertable tongue (4) in the pocket (5) being limited by a stop.
Patent NZ-333561-A (NZ)
Title: Package for meatrolls packaged in film having food adhesion layer containing high vicat softening pointolefin/acrylic acid copolymer
Inventor: RAMESH RAM K
IPC: A22C13/00
Filed: 1997-06-24
Abstract: This packaged product has a film configured around a cooked meat product where the cooked meat product is adhered to a meat-contact surface of the film. The meat-contact surface of the film comprises an olefin/acrylic acid copolymer having a Vicat softening point, in °F, of at least 232 minus 5 multiplied by the weight percent of acrylic acid mer in the olefin/acrylic acid copolymer. The cooked meat product comprises at least one member selected from the group consisting of sausage, bologna, mortadella, braunschweiger, and high-water-added ham. The olefin/acrylic acid copolymer has been found to adhere well to high fat/low protein meat products, is orientable for the formation of heat-shrinkable films, and provides a stronger seal than previously available olefin/acrylic acid copolymers.
Patent NZ-337298-A (NZ)
Title: N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
Inventor: VENKATESAN MUDUMBAI ARANAPAKAM
IPC: A61K31/381
Filed: 1998-02-17
Abstract: Preparation of a composition comprising a compound of Formula (I) wherein R1, R2, R3, R4 are defined within, which acts to inhibit matrix metalloproteinases (MMPs) and TNF-a converting enzyme (TACE), for the treatment of arthritis, tumor metastasis, bone disease and HIV infection.
Patent NZ-501340-A (NZ)
Title: Redirection of cellular immune response by administering protein-tyrosine kinase chimeras
Inventor: SEED BRIAN
IPC: C07K14/735
Filed: 1996-01-24
Abstract: Disclosed is a method of directing a cellular response in a mammal by expressing in a cell of the mammal a chimeric receptor which causes the cells to specifically recognize and destroy an infective agent, a cell infected with an infective agent, a tumor or cancerous cell, or an autoimmune-generated cell. The chimeric receptor includes an extracellular portion which is capable of specifically recognizing and binding the target cell or target infective agent, and (b) an intracellular portion of a protein-tyrosine kinase which is capable of signalling the therapeutic cell to destroy a receptor-bound target cell or a receptor-bound target infective agent. Also disclosed are cells which express the chimeric receptors and DNA encoding the chimeric receptors.
Patent NZ-503443-A (NZ)
Title: Aldehyde reductase or aldose reductase for removing free radicals such as hydrogen peroxide in plants during environmental stress conditions by reducing 4-hydroxy-nonenal in the presence of NADPH
Inventor: HOVATH GABOR
IPC: C12N5/10
Filed: 1998-11-18
Abstract: Transgenic plant cells, breeding materials, plant parts and plants in which the expression level of the aldose reductase-homologous protein is increased and which show higher resistance against stress conditions of different origin. Also described are DNA molecules and vectors suitable for the expression of aldose reductase-homologous protein and processes for the preparation of plant cells overproducing aldose reductase-homologous protein. The inserts are suitable for reducing damage in crops caused by harmful biotic and abiotic stress conditions and for enhancing harvest prospects.
Patent NZ-504773-A (NZ)
Title: Use of abscisic acid in post-cryopreservation recovery medium to improve growth of embryogenic cultures retrieved from cryopreservation
Inventor: BECWAR MICHAEL RYAN
IPC: A01H4/00
Filed: 2000-05-25
Abstract: A method for recovering embryogenic cultures of coniferous plants, ie Pinus spp, which have been subjected to cyropreservation which comprises: (a) thawing the embryogenic culture; and (b) culturing the thawed embryogenic on post-cryopreservation recovery medium containing nutrients, a gelling agent, abscisic acid and additional phytohormone to recover the embryogenic culture.
Patent NZ-504988-A (NZ)
Title: Cobalt and titania based fisher-tropsch catalyst
Inventor: GEERLINGS JACOBUS JOHANNES COR
IPC: B01J37/00
Filed: 1998-12-28
Abstract: The process for the preparation of a cobalt-containing catalyst or catalyst precursor comprises: (a) mixing (1) titania or a titania precursor, which is an intermediate form formed by heating titanium hydroxide to convert it to titania, (2) a liquid, and (3) metallic cobalt powder or a cobalt compound, which powder or compound is at least partially insoluble in the amount of liquid used, to form a mixture, (b) shaping and drying of the mixture, and (c) calcination of the composition thus obtained. A catalyst obtained by the above process is also described. A process for the preparation of hydrocarbons (and the hydrocarbons thus obtained) comprising contacting a mixture of carbon monoxide and hydrogen with a catalyst as described above is also described.
Patent NZ-505277-A (NZ)
Title: A cutting blade with a dulled insert of docile material
Inventor: ALLEN WALLIS RAYMOND
IPC: B26B9/00
Filed: 1998-12-17
Abstract: A cutting blade includes a handle (11), a blade (12) and a cutting edge (13). The blade is characterised in that it includes an insert (14) of docile material. The docile insert (14) will not take on a sharpened edge such that the blade will not puncture unintended areas during animal processing operations.
Patent NZ-509116-A (NZ)
Title: Interlocking modular ramp system for skateboarders and skaters
Inventor: HOCKING RORY GARTH
IPC: A63C19/10
Filed: 2000-12-22
Abstract: A method to interlock a plurality of ramp modules (20) is disclosed. The ramps (20) are typically used by skateboarders, skaters or bike riders. To ensure safety of the users thereof, the ramps must be sufficiently engaged with one another to provide smooth running surface(s), while allowing for detachability. For this, interlocks (22,23) are used. Interlocks on a common wall will be aligned in one direction. On the other hand, interlocks on different walls can be aligned in different directions as shown. The interlocks work by coming into a locking contact with a complimentary interlock, such as interlock 23 coming into contact with interlock 22 on a different ramp module.
Patent NZ-510662-A (NZ)
Title: Scaffolding apparatus with brackets to abut inner and outer sides of studs
Inventor: HUDSON DARREN PHILIP
IPC: E04G5/06
Filed: 2001-03-21
Abstract: A scaffolding apparatus for use on a building during its construction, said scaffolding apparatus comprising a plurality of fixing bracket members each said bracket member having a pair of elongated angled members aligned above and below respectively of the longitudinal axis of said fixing bracket member the lower angled member being adapted to be fixed abutting against and extending along the longitudinal axis of the outwardly facing side of said stud with the upper angled member being adapted to be fixed abutting against and extending along the longitudinal axis of the inwardly facing side of the stud, both said elongate angled members being fixed in a vertically elongate orientation to at least one side of said stud member, wherein said plurality of fixing bracket members are arranged when installed, to receive planks on top to provide a platform and have at their free ends a stop means to prevent planks from falling off when in use.
Patent NZ-514166-A (NZ)
Title: Diagnosis of lysosomal storage disorders using saposins and other markers
Inventor: MEIKLE PETER JOHN
IPC: C12Q1/68
Filed: 2000-03-17
Abstract: A method of diagnosing or monitoring a lysosomal storage disorder, such as Pompe's disease, in a patient, comprising: measuring a first level of a first saposin in a first tissue sample obtained from the patient, wherein (i) the first saposin is saposin A, saposin B, saposin C, saposin D or a combination thereof; (ii) the first level is an indicator of the presence or extent of the disorder in the patient; and (iii) the first tissue sample is a plasma, serum, whole blood, urine or amniotic fluid sample. The method may further comprising measuring a level of Lamp-1 or Lamp-2 in a second tissue sample obtained from the patient and measuring a level of alpha-glucosidase in a third tissue sample.
Patent NZ-515408-A (NZ)
Title: 5-phenyl-pyrimidine derivatives
Inventor: BOES MICHAEL
IPC: A61P25/28
Filed: 2000-05-24
Abstract: The invention relates to compounds of general formula (I) wherein R1 is hydrogen or halogen; R2 is hydrogen, halogen, lower alkyl or lower alkoxy; R3 is halogen, trifluoromethyl, lower alkoxy or lower alkyl; R4/R4' are independently from each other hydrogen or lower alkyl; R5 is lower alkyl, lower alkoxy, amino, hydroxy, hydroxy-lower alkyl, -(CH2)n-piperazinyl, optionally substituted by lower alkyl, -(CH2)n-morpholinyl, -(CH2)n+1-imidazolyl, -O- (CH2)n+1-morpholinyl, -O-(CH2)n+1-piperidinyl, lower alkyl- sulfanyl, lower alkyl-sulfonyl, benzylamino, -NH- (CH2)n+1N(R4")2, -(CH2)n-NH-(CH2)n+1N(R4")2, - (CH2)n+1N(R4")2, or -O-(CH2)n+1N(R<4">)2, wherein R4"is hydrogen or lower alkyl; R6 is hydrogen; R2 and R6 or R1 and R6 may be together with the two carbon ring atoms - CH=CH-CH=CH-, with the proviso that n for R1 is 1; n is independently 0 - 2; and X is -C(O)N(R4")- or -N(R4")C(O)-; and pharmaceutically acceptable acid addition salts thereof. Compounds of formula (I) have a high affinity to the NK-1 receptor. They are therefore useful for the treatment or diseases which relate to this receptor.